is qsymia a tirzepatide vs Mounjaro: Which Better for Weight Loss in 2025? Qsymia: Package Insert / Prescribing

(26) GLP-1 use was associated with a 43% lower risk of LLA compared to sulfonylureas, with an adjusted hazard ratio (HR) of 0.57 (95% CI: 0.390.84)

Theres a lot of stairs and, like, as I get older, I think if I had been at the same weight, that would have been a massive problem

But Lilly is hitting a bigger market

Expected Benefits of Retatrutide Based on early evidence, potential benefits may include: Significant weight loss beyond existing GLP1 medications Improved appetite control Better metabolic health markers Potential benefits for prediabetes or type 2 diabetes Enhanced energy expenditure due to glucagon activity Once weekly dosing Final benefits will only be confirmed after Phase 3 trials